Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insight into in vitro thymidine phosphorylase and in silico molecular docking studies: identification of hybrid thiazole bearing Schiff base derivatives. | Z Naturforsch C J Biosci | 2025 | 39908583 | PubTator, text mining | PubMed |
| m6A related metabolic genes in breast cancer and their relationship with prognosis. | Int Immunopharmacol | 2025 | 39889412 | PubTator, text mining | PubMed |
| Beyond chemotherapy: Exploring 5-FU resistance and stemness in colorectal cancer. | Eur J Pharmacol | 2025 | 39863147 | PubTator, text mining | PubMed |
| From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents. | Pharmaceuticals (Basel) | 2025 | 39861135 | PubTator, text mining | PubMed |
| Proteomics unveil candidate biomarkers and pathogenesis of subacute thyroiditis. | Endocr Connect | 2025 | 39807704 | PubTator, text mining | PubMed |
| Transcription factor MAZ activates the transcription of hypomethylated TYMP in ccRCC. | Funct Integr Genomics | 2025 | 39797954 | PubTator, text mining | PubMed |
| Causal associations between circulating protein ratios and drug resistance in papillary thyroid cancer: a Mendelian randomization study. | Discov Oncol | 2025 | 39754686 | PubTator, text mining | PubMed |
| Thymidine phosphorylase participates in platelet activation and promotes inflammation in rheumatoid arthritis. | Toxicol Appl Pharmacol | 2025 | 39732205 | PubTator, text mining | PubMed |
| TBK1 Reprograms Metabolism in Breast Cancer: An Integrated Omics Approach. | J Proteome Res | 2025 | 39670797 | PubTator, text mining | PubMed |
| Effect of Concentration of TiO2 Nanoparticles on Thiadiazole Derivative and Their Molecular Docking Study. | J Fluoresc | 2025 | 39644371 | PubTator, text mining | PubMed |
| ADAMDEC1 promotes cervical squamous cell carcinoma by enhancing the JAK/STAT signaling pathway through modulation of TYMP. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39625490 | PubTator, text mining | PubMed |
| Integrated proteomics and scRNA-seq analyses of ovarian cancer reveal molecular subtype-associated cell landscapes and immunotherapy targets. | Br J Cancer | 2025 | 39548315 | PubTator, text mining | PubMed |
| Rheumatoid arthritis and gliostatin: a two-sample Mendelian randomization analysis and RT-PCR validation. | Clin Rheumatol | 2025 | 39352437 | PubTator, text mining | PubMed |
| Eradication of Cancer Cells Using Doxifluridine and Mesenchymal Stem Cells Expressing Thymidine Phosphorylase. | Bioengineering (Basel) | 2024 | 39768012 | PubTator, text mining | PubMed |
| Thymidine Phosphorylase Promotes Abdominal Aortic Aneurysm via VSMC Modulation and Matrix Remodeling in Mice and Humans. | Cardiovasc Ther | 2024 | 39742002 | PubTator, text mining | PubMed |
| Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy. | Nat Commun | 2024 | 39562821 | PubTator, text mining | PubMed |
| Identification and validation of oxidative stress-related genes in primary open-angle glaucoma by weighted gene co-expression network analysis and machine learning. | Medicine (Baltimore) | 2024 | 39560561 | PubTator, text mining | PubMed |
| Thymidine Phosphorylase Imaging Probe for Differential Diagnosis of Metabolic dysfunction-associated Steatohepatitis. | Mol Imaging Biol | 2024 | 39538096 | PubTator, text mining | PubMed |
| Advances in drug delivery systems utilizing blood cells and their membrane-derived microvesicles. | Drug Deliv | 2024 | 39520082 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of Doxifluridine Derivatives as Nitroreductase-Responsive Anticancer Prodrugs. | Molecules | 2024 | 39519718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=6